KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 64 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $14,629,156,000 | -17.0% | 291,708 | -42.6% | 0.01% | -22.2% |
Q4 2014 | $17,631,936,000 | +62238.9% | 508,418 | -41.1% | 0.01% | -40.0% |
Q3 2014 | $28,284,000 | -16.5% | 863,355 | -2.2% | 0.02% | -16.7% |
Q2 2014 | $33,875,000 | -99.9% | 882,853 | +9.2% | 0.02% | 0.0% |
Q1 2014 | $32,139,876,000 | +2.3% | 808,347 | -3.9% | 0.02% | 0.0% |
Q4 2013 | $31,426,178,000 | +1.0% | 841,397 | +23.3% | 0.02% | -5.3% |
Q3 2013 | $31,105,967,000 | +140.6% | 682,313 | +42.8% | 0.02% | +111.1% |
Q2 2013 | $12,926,573,000 | – | 477,877 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AlpInvest Partners B.V. | 33,271 | $1,277,000 | 4.55% |
Palo Alto Investors LP | 949,959 | $36,450,000 | 2.71% |
Redmile Group, LLC | 560,356 | $21,501,000 | 2.61% |
SENZAR ASSET MANAGEMENT, LLC | 124,900 | $4,792,000 | 1.83% |
Aureus Asset Management, LLC | 152,662 | $5,858,000 | 1.46% |
PFM Health Sciences, LP | 952,715 | $36,556,000 | 0.73% |
REGENTATLANTIC CAPITAL LLC | 176,454 | $6,771,000 | 0.63% |
Polar Capital LLP | 519,398 | $19,927,000 | 0.42% |
FNY Managed Accounts LLC | 2,500 | $95,925,000 | 0.35% |
Partner Investment Management, L.P. | 36,173 | $1,388,000 | 0.28% |